المؤلفون: Robert, C, Lewis, KD, Gutzmer, R, Stroyakovskiy, D, Gogas, H, Protsenko, S, Pereira, RP, Eigentler, T, Rutkowski, P, Demidov, L, Caro, I, Forbes, H, Shah, K, Yan, Y, Li, H, McArthur, GA, Ascierto, PA

العلاقة: pii: S0923-7534(22)00103-X; Robert, C., Lewis, K. D., Gutzmer, R., Stroyakovskiy, D., Gogas, H., Protsenko, S., Pereira, R. P., Eigentler, T., Rutkowski, P., Demidov, L., Caro, I., Forbes, H., Shah, K., Yan, Y., Li, H., McArthur, G. A. & Ascierto, P. A. (2022). Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAF(V600) mutation-positive melanoma. ANNALS OF ONCOLOGY, 33 (5), pp.544-555. https://doi.org/10.1016/j.annonc.2022.01.076Test.; http://hdl.handle.net/11343/308716Test

الإتاحة: https://doi.org/10.1016/j.annonc.2022.01.076Test
http://hdl.handle.net/11343/308716Test

المؤلفون: Ascierto, PA, Dréno, B, Larkin, J, Ribas, A, Liszkay, G, Maio, M, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Atkinson, V, Dutriaux, C, Garbe, C, Hsu, J, Jones, S, Li, H, McKenna, E, Voulgari, A, McArthur, GA

المساهمون: Larkin, James

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Azetidines, Follow-Up Studies, Humans, Melanoma, Mutation, Piperidines, Proto-Oncogene Proteins B-raf, Skin Neoplasms, Vemurafenib

جغرافية الموضوع: United States

وصف الملف: Print; 5235; application/pdf

العلاقة: 1078-0432.CCR-21-0809; Clinical Cancer Research, 2021, 27 (19), pp. 5225 - 5235; https://repository.icr.ac.uk/handle/internal/5284Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0809Test
https://repository.icr.ac.uk/handle/internal/5284Test

المؤلفون: Dréno, B, Ascierto, PA, Atkinson, V, Liszkay, G, Maio, M, Mandalà, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Dutriaux, C, Garbe, C, Bartley, K, Karagiannis, T, Chang, I, Rooney, I, Koralek, DO, Larkin, J, McArthur, GA, Ribas, A

المساهمون: Larkin, James

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Azetidines, Double-Blind Method, Female, Humans, Longitudinal Studies, Male, Melanoma, Mutation, Piperidines, Placebos, Proto-Oncogene Proteins B-raf, Quality of Life, Vemurafenib

جغرافية الموضوع: England

وصف الملف: Print-Electronic; 784; application/pdf

العلاقة: bjc2017488; British Journal of Cancer, 2018, 118 (6), pp. 777 - 784; https://repository.icr.ac.uk/handle/internal/5296Test

الإتاحة: https://doi.org/10.1038/bjc.2017.488Test
https://repository.icr.ac.uk/handle/internal/5296Test

المؤلفون: Dummer, R., Gyorki, D., Hyngstrom, J., Berger, A., Conry, R., Demidov, L., Ning, L., Lawrence, T., Faries, M., Ross, M.

المساهمون: Amgen

المصدر: Annals of Oncology ; volume 33, page S1406 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.08.037Test
https://api.elsevier.com/content/article/PII:S0923753422039151?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422039151?httpAccept=text/plainTest

المؤلفون: Del Vecchio, M., Atkinson, V.G., Ryll, B., Menzies, A.M., Aubin, F., Chiarion Sileni, V., Ferraresi, V., Lesimple, T., Rinaldi, G., Saiag, P., Robert, C., Dutriaux, C., Gogas, H.J., Demidov, L., Gupta, A., Banerjee, H., Sudhir, S., Miranda, F., Lau, M.R., Grob, J.J.

المصدر: Annals of Oncology ; volume 33, page S914 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.07.932Test
https://api.elsevier.com/content/article/PII:S0923753422027831?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753422027831?httpAccept=text/plainTest

المؤلفون: Robert, C., Lewis, K.D., Gutzmer, R., Stroyakovskiy, D., Gogas, H., Protsenko, S., Pereira, R.P., Eigentler, T., Rutkowski, P., Demidov, L., Caro, I., Forbes, H., Shah, K., Yan, Y., Li, H., McArthur, G.A., Ascierto, P.A.

المساهمون: F. Hoffmann-La Roche Ltd

المصدر: Annals of Oncology ; volume 33, issue 5, page 544-555 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2022.01.076Test
https://api.elsevier.com/content/article/PII:S092375342200103X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342200103X?httpAccept=text/plainTest

المؤلفون: Ascierto, PA, Dreno, B, Larkin, J, Ribas, A, Liszkay, G, Maio, M, Mandala, M, Demidov, L, Stroyakovskiy, D, Thomas, L, de la Cruz-Merino, L, Atkinson, V, Dutriaux, C, Garbe, C, Hsu, J, Jones, S, Li, H, McKenna, E, Voulgari, A, McArthur, GA

العلاقة: pii: 1078-0432.CCR-21-0809; Ascierto, P. A., Dreno, B., Larkin, J., Ribas, A., Liszkay, G., Maio, M., Mandala, M., Demidov, L., Stroyakovskiy, D., Thomas, L., de la Cruz-Merino, L., Atkinson, V., Dutriaux, C., Garbe, C., Hsu, J., Jones, S., Li, H., McKenna, E., Voulgari, A. & McArthur, G. A. (2021). 5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF(V600) Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study. CLINICAL CANCER RESEARCH, 27 (19), pp.5225-5235. https://doi.org/10.1158/1078-0432.CCR-21-0809Test.; http://hdl.handle.net/11343/307859Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-21-0809Test
http://hdl.handle.net/11343/307859Test

المؤلفون: Gogas, H., Dréno, B., Larkin, J., Demidov, L., Stroyakovskiy, D., Eroglu, Z., Francesco Ferrucci, P., Pigozzo, J., Rutkowski, P., Mackiewicz, J., Rooney, I., Voulgari, A., Troutman, S., Pitcher, B., Guo, Y., Yan, Y., Castro, M., Mulla, S., Flaherty, K., Arance, A.

المساهمون: F. Hoffmann-La Roche, Genentech Inc

المصدر: Annals of Oncology ; volume 32, issue 3, page 384-394 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2020.12.004Test
https://api.elsevier.com/content/article/PII:S092375342043203X?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S092375342043203X?httpAccept=text/plainTest

المؤلفون: Ribas, A., Chesney, J., Long, G.V., Kirkwood, J.M., Dummer, R., Puzanov, I., Hoeller, C., Gajewski, T.F., Gutzmer, R., Rutkowski, P., Demidov, L., Arenberger, P., Shin, S.J., Ferrucci, P.F., Diede, S.J., Anderson, J.R., Treichel, S., Chan, E., Hodi, F.S., Gogas, H.J.

المساهمون: Amgen

المصدر: Annals of Oncology ; volume 32, page S868-S869 ; ISSN 0923-7534

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.1422Test
https://api.elsevier.com/content/article/PII:S0923753421036516?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753421036516?httpAccept=text/plainTest

المؤلفون: Nathan P., Ascierto P. A., Haanen J., Espinosa E., Demidov L., Garbe C., Guida M., Lorigan P., Chiarion-Sileni V., Gogas H., Maio M., Fierro M. T., Hoeller C., Terheyden P., Gutzmer R., Guren T. K., Bafaloukos D., Rutkowski P., Plummer R., Waterston A., Kaatz M., Mandala M., Marquez-Rodas I., Munoz-Couselo E., Dummer R., Grigoryeva E., Young T. C., Schadendorf D.

المساهمون: Nathan P., Ascierto P.A., Haanen J., Espinosa E., Demidov L., Garbe C., Guida M., Lorigan P., Chiarion-Sileni V., Gogas H., Maio M., Fierro M.T., Hoeller C., Terheyden P., Gutzmer R., Guren T.K., Bafaloukos D., Rutkowski P., Plummer R., Waterston A., Kaatz M., Mandala M., Marquez-Rodas I., Munoz-Couselo E., Dummer R., Grigoryeva E., Young T.C., Schadendorf D.

مصطلحات موضوعية: Acral, Advanced melanoma, Ipilimumab, Mucosal, Nivolumab, Ocular

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31445199; info:eu-repo/semantics/altIdentifier/wos/WOS:000486628600018; volume:119; firstpage:168; lastpage:178; numberofpages:11; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/2318/1717995Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85070912965; http://www.journals.elsevier.com/european-journal-of-cancerTest/

الإتاحة: https://doi.org/10.1016/j.ejca.2019.07.010Test
http://hdl.handle.net/2318/1717995Test
http://www.journals.elsevier.com/european-journal-of-cancerTest/